End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 THB | +0.69% | +2.11% | -7.64% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- The firm trades with high earnings multiples: 25.32 times its 2024 earnings per share.
- The company's enterprise value to sales, at 3.5 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.64% | 860M | B | ||
+14.10% | 81.84B | C+ | ||
-30.15% | 70.69B | B- | ||
+9.37% | 29.03B | C+ | ||
-11.90% | 16.97B | B | ||
-0.36% | 16.83B | A- | ||
-1.12% | 15.28B | A- | ||
+5.90% | 12.41B | A- | ||
+35.78% | 12.26B | B- | ||
-4.20% | 11.86B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHG Stock
- Ratings Chularat Hospital